Stock listing

0QZU Stock Price, News, Filings & Events — Vertex Pharmaceuticals Incorporated

Selected listing: 0QZU · LSE · USD · GB

The 0QZU:LSE listing represents Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on developing innovative therapies for serious diseases. The company is known for its advancements in treating cystic fibrosis and has a robust pipeline of drug candidates aimed at various genetic diseases. Recent news highlights Vertex's ongoing clinical trials and partnerships that may enhance its market position. Investors can stay informed through the latest filings and upcoming events that reflect the company's strategic direction and growth potential.

0QZU:LSEUSDGBUpdated July 24, 2026
Vertex Pharmaceuticals Incorporated logo
Ticker
0QZU:LSE
Asset type
Stock
Market cap
$121.16B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSE
Currency
USD

Vertex Pharmaceuticals Incorporated 0QZU:LSE stock context

The 0QZU:LSE listing represents Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on developing innovative therapies for serious diseases. The company is known for its advancements in treating cystic fibrosis and has a robust pipeline of drug candidates aimed at various genetic diseases. Recent news highlights Vertex's ongoing clinical trials and partnerships that may enhance its market position. Investors can stay informed through the latest filings and upcoming events that reflect the company's strategic direction and growth potential.

Research Vertex Pharmaceuticals Incorporated

Alternate listings